Alpha Tau Medical Ltd.

DRTS40

Penny Stock

$2.52arrow_drop_up6.03%$0.14

Penny Stock

DRTS40

$2.52

arrow_drop_up6.03%$0.14

Penny Stock

Performance History

Key Stats
Open	$2.34
Prev. Close	$2.32
EPS	-0.43
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$177.32M
PE Ratio	-

	LOW	HIGH
Day Range	2.32	2.59
52 Week Range	1.75	3.90

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.43

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Ltd. (DRTS) is a leading medical technology company that specializes in the development and commercialization of a breakthrough cancer treatment called Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy). This innovative therapy utilizes alpha radiation to target and destroy cancer cells, providing an effective and precise treatment option for patients. With over a decade of research and development, Alpha Tau Medical has achieved remarkable success in clinical trials, demonstrating superior oncological outcomes and minimal side effects compared to traditional treatments.

The stock price history of Alpha Tau Medical Ltd. (DRTS) reflects the company's growth and potential. It has experienced steady upward trends, driven by positive news, advancements in research, and successful clinical trials. Investors have recognized the tremendous potential of Alpha DaRT and its ability to revolutionize cancer treatment, leading to increased market interest and demand for the stock.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Uzi Sofer
Headquarters: Jerusalem
Employees: 94
Exchange: NASDAQ

Keep an eye on Alpha Tau Medical Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Alpha Tau Medical Ltd.'s (DRTS) price per share?

The current price per share for Alpha Tau Medical Ltd. (DRTS) is $2.53. The stock has seen a price change of $0.14 recently, indicating a 6.03% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Alpha Tau Medical Ltd. (DRTS)?

For Alpha Tau Medical Ltd. (DRTS), the 52-week high is $3.9, which is 54.18% from the current price. The 52-week low is $1.75, the current price is 44.54% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Alpha Tau Medical Ltd. (DRTS) a growth stock?

Alpha Tau Medical Ltd. (DRTS) has shown an average price growth of -3.36% over the past three years. It has received a score of 10 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Alpha Tau Medical Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Alpha Tau Medical Ltd. (DRTS) stock price performance year to date (YTD)?

As of the latest data, Alpha Tau Medical Ltd. (DRTS) has a year-to-date price change of -15.68%. Over the past month, the stock has experienced a price change of 13.94%. Over the last three months, the change has been 11.92%. Over the past six months, the figure is -0.02%.

help

Is Alpha Tau Medical Ltd. (DRTS) a profitable company?

Alpha Tau Medical Ltd. (DRTS) has a net income of -$29.16M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at $35.68M. Furthermore, the EBITDA is -$35.22M.

help

What is the market capitalization of Alpha Tau Medical Ltd. (DRTS)?

Alpha Tau Medical Ltd. (DRTS) has a market capitalization of $177.33M. The average daily trading volume is 2.42, indicating the stock's liquidity and investor engagement.